Regeneron Pharmaceuticals Inc (REGN)
941.77
+4.16
(+0.44%)
USD |
NASDAQ |
May 03, 10:11
Regeneron Pharmaceuticals Gross Profit (TTM): 11.30B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.30B |
September 30, 2023 | 11.26B |
June 30, 2023 | 10.95B |
March 31, 2023 | 10.76B |
December 31, 2022 | 10.61B |
September 30, 2022 | 11.71B |
June 30, 2022 | 12.09B |
March 31, 2022 | 13.97B |
December 31, 2021 | 13.63B |
September 30, 2021 | 11.73B |
June 30, 2021 | 10.76B |
March 31, 2021 | 7.987B |
December 31, 2020 | 7.377B |
September 30, 2020 | 6.949B |
June 30, 2020 | 6.447B |
March 31, 2020 | 6.203B |
December 31, 2019 | 5.792B |
September 30, 2019 | 4.413B |
June 30, 2019 | 4.448B |
March 31, 2019 | 4.532B |
December 31, 2018 | 4.728B |
September 30, 2018 | 5.943B |
June 30, 2018 | 5.786B |
March 31, 2018 | 5.637B |
December 31, 2017 | 5.475B |
Date | Value |
---|---|
September 30, 2017 | 5.151B |
June 30, 2017 | 4.930B |
March 31, 2017 | 4.706B |
December 31, 2016 | 4.561B |
September 30, 2016 | 4.396B |
June 30, 2016 | 4.248B |
March 31, 2016 | 4.014B |
December 31, 2015 | 3.711B |
September 30, 2015 | 3.467B |
June 30, 2015 | 3.108B |
March 31, 2015 | 2.818B |
December 31, 2014 | 2.615B |
September 30, 2014 | 2.434B |
June 30, 2014 | 2.322B |
March 31, 2014 | 2.121B |
December 31, 2013 | 1.949B |
September 30, 2013 | 1.772B |
June 30, 2013 | 1.621B |
March 31, 2013 | 1.485B |
December 31, 2012 | 1.294B |
September 30, 2012 | 1.030B |
June 30, 2012 | 724.42M |
March 31, 2012 | 549.28M |
December 31, 2011 | 441.61M |
September 30, 2011 | 454.70M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
4.413B
Minimum
Sep 2019
13.97B
Maximum
Mar 2022
9.389B
Average
10.76B
Median
Jun 2021
Gross Profit (TTM) Benchmarks
Vertex Pharmaceuticals Inc | 8.607B |
Eli Lilly and Co | 28.80B |
AbbVie Inc | 33.88B |
Bristol-Myers Squibb Co | 34.48B |
Amgen Inc | 19.74B |